Physician profile
James Mccaffrey
NPI 1427497676
$3,529.20
in general payments reported to CMS, 2019-2025
26 companies · $498 in 2025
The $498 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $397 · 2020: $77.22 · 2021: $265 · 2022: $1,085 · 2023: $623 · 2024: $583 · 2025: $498.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,704.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,704.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $714.29 | 2019-2025 | Watchman Access System, General - Brady, Farapulse |
| Biosense Webster, INC. | $688.34 | 2019-2025 | Carto 3, Octaray Mapping Catheter |
| Abbott Laboratories | $629.24 | 2019-2025 | Ensite, Amplatzer, Assurity |
| Elutia, INC. | $276.07 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $177.20 | 2023-2025 | |
| Biotronik INC. | $148.78 | 2019-2022 | |
| Impulse Dynamics (USA) INC. | $134.38 | 2023-2024 | Optimizer, Optimizer |
| E.R. Squibb & Sons, L.L.C. | $107.75 | 2021-2023 | Eliquis |
| Pfizer INC. | $82.56 | 2022-2025 | |
| Medtronic Vascular, INC. | $69.08 | 2019 | |
| Abiomed | $64.72 | 2019-2022 | |
| Cardiofocus, INC. | $61.12 | 2022 | |
| Acutus Medical, INC. | $56.84 | 2022 | |
| Angiodynamics, INC. | $51.16 | 2025 | Auryon Laser System 100-120 Vac |
| Kiniksa Pharmaceuticals, Ltd. | $42.12 | 2023 | Arcalyst |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.90 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $24.61 | 2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $21.08 | 2023 | Xarelto |
| Inspire Medical Systems, INC. | $19.95 | 2025 | Inspire |
| Siemens Medical Solutions USA, INC. | $19.39 | 2019 | |
| Philips North America LLC | $18.84 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.10 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.33 | 2023 | |
| Amgen INC. | $15.96 | 2022 | |
| W. L. Gore & Associates, INC. | $15.16 | 2020 | |
| Medtronic, INC. | $14.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mccaffrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.